Crossref
Efficacy of roxadustat in maintenance hemodialysis patients with erythropoietin-hyporesponsive anemia
Clinical Nephrology · 2024
DOI: 10.5414/cn111109 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Nephrology, 2024. Verfasst von Xiaoshuang Wang und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Anemia, Erythropoietin. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
AnemiaErythropoietinHumansMiddle AgedEpoetin AlfaGlycineHemoglobinsIsoquinolinesRenal DialysisRetrospective Studies
Substanzen
Epoetin AlfaErythropoietinGlycineHemoglobinsIsoquinolines
Zitieren
APA
Wang, X., Cai, H., Xu, H., & Chen, L. (2024). Efficacy of roxadustat in maintenance hemodialysis patients with erythropoietin-hyporesponsive anemia. Clinical Nephrology. https://doi.org/10.5414/cn111109
Vancouver
Wang X, Cai H, Xu H, Chen L. Efficacy of roxadustat in maintenance hemodialysis patients with erythropoietin-hyporesponsive anemia. Clinical Nephrology. 2024. doi:10.5414/cn111109
BibTeX
@article{Wang2024,
author = {Wang, Xiaoshuang and Cai, Hezhou and Xu, Haifan and Chen, Liqun},
title = {Efficacy of roxadustat in maintenance hemodialysis patients with erythropoietin-hyporesponsive anemia},
journal = {Clinical Nephrology},
year = {2024},
doi = {10.5414/cn111109}
}
EUVIMED